Overall: Resource-based Center for Musculoskeletal Disorders Research (Overall Application)
Project Number2P30AR069619-06
Former Number5P30AR069619-05
Contact PI/Project LeaderSOSLOWSKY, LOUIS J
Awardee OrganizationUNIVERSITY OF PENNSYLVANIA
Description
Abstract Text
The Penn Center for Musculoskeletal Disorders (PCMD) will continue to provide critical resources and
programs to, and enhance research productivity of, investigators to address multidisciplinary research
strategies for musculoskeletal problems. The overall goal of this Center is to promote cooperative interactions
among investigators, accelerate and enrich the effectiveness and efficiency of ongoing research, foster new
collaborations and new research, and ultimately, translate our research efforts into better and new therapies for
musculoskeletal disorders. The Center theme is “Musculoskeletal Development, Disease, Injury and Repair”
while addressing 3 Research Thrust areas. Our PCMD is the home for musculoskeletal research across the
Penn campus and a hub for the musculoskeletal community across the region and neighboring states .
One focus of our Center is to bridge themes, approaches, and paradigms across musculoskeletal tissues
which may be overlooked when studying a single tissue. Since approaches used to evaluate mechanisms in
one tissue could aid researchers in other areas, our Center will foster this critical cross-talk. To further focus,
we will emphasize small animal models utilizing unique and sophisticated methods that cross length scales.
The PCMD will provide unique expertise and tools to investigate musculoskeletal tissues across such scales.
Thus, the primary overall Aims of this Center remain to enhance and advance the research productivity of
investigators in musculoskeletal development, disease, injury and repair by providing: Aim 1: Innovation within
critical resource core facilities in areas that cross disciplines, length scales, and hierarchies. These core
facilities remain µCT Imaging, Biomechanics, and Histology; Aim 2: A pilot and feasibility grant program, with
direct mentorship; and Aim 3: Educational and research enrichment programs, through which members can
learn from national leaders and from each other. High quality musculoskeletal research is being conducted by
many groups at Penn, in the region, and neighboring states. While many bring sophisticated approaches to
musculoskeletal problems, few have the required expertise and facilities to perform the broad range of rigorous
and specialized assays in their own labs. The Center will provide opportunities to integrate techniques to define
mechanisms for tissue function, injury, development, degeneration, repair, and regeneration, with the ultimate
goal of advancing diagnosis, treatment, and prevention of diseases and injuries of the musculoskeletal system.
There is also an intangible feature of our Center. Although our musculoskeletal program is strong nationally,
the Penn biomedical research community is large and diverse. As such, the Center serves as an essential
mechanism to highlight our successes and the importance of musculoskeletal research across campus, as well
as to institutional leadership. Having a strong voice for musculoskeletal researchers for our region is critical to
support our collective and individual research goals. In these ways, the Center - with essential support from the
P30 - has become and remains an indispensable resource and advocate for our community.
Public Health Relevance Statement
The Penn Center for Musculoskeletal Disorders (PCMD) will continue to provide critical resources and
programs to, and enhance research productivity of, investigators to address multidisciplinary research
strategies for musculoskeletal problems. The overall goal of this Center is to promote cooperative interactions
among investigators, accelerate and enrich the effectiveness and efficiency of ongoing research, foster new
collaborations and new research, and ultimately, translate our research efforts into better and new therapies for
musculoskeletal disorders. Our PCMD is the home for musculoskeletal research across the Penn campus and
a hub for the musculoskeletal community across the region and neighboring states .
National Institute of Arthritis and Musculoskeletal and Skin Diseases
CFDA Code
846
DUNS Number
042250712
UEI
GM1XX56LEP58
Project Start Date
01-July-2016
Project End Date
30-June-2026
Budget Start Date
01-September-2021
Budget End Date
30-June-2022
Project Funding Information for 2021
Total Funding
$826,622
Direct Costs
$508,690
Indirect Costs
$317,932
Year
Funding IC
FY Total Cost by IC
2021
National Institute of Arthritis and Musculoskeletal and Skin Diseases
$826,622
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 2P30AR069619-06
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 2P30AR069619-06
Patents
No Patents information available for 2P30AR069619-06
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 2P30AR069619-06
Clinical Studies
No Clinical Studies information available for 2P30AR069619-06
News and More
Related News Releases
No news release information available for 2P30AR069619-06
History
No Historical information available for 2P30AR069619-06
Similar Projects
No Similar Projects information available for 2P30AR069619-06